Quantitative Modeling and Analysis of TGF-ß-Induced Erk/MAPK and Smad Signaling

  • Type:
    Conference Presentation
  • Conference Type:
    AIChE Annual Meeting
  • Presentation Date:
    November 9, 2010
  • Duration:
    30 minutes
  • Skill Level:
    Intermediate
  • PDHs:
    0.50

Share This Post:

Transforming growth factor ß (TGF-ß), which plays a pivotal role in regulating a wide array of cellular and physiologic processes in both normal and pathological cells, is known to function as a potent tumor suppressor during the early stage of tumorigenesis, primarily by inhibiting cell proliferation and inducing apoptosis. However, in the late phases of tumor progression, the role of TGF-ß appears to become one of tumor promotion, apparently supporting growth, subverting the immune system, and also facilitating epithelial-to-mesenchymal transition (EMT), invasion and angiogenesis. While these various cellular responses are known to be induced via several TGF-ß-driven signaling cascades that include both the canonical Smad and non-Smad pathways, significant research efforts have been devoted almost exclusively to the canonical Smad-meditated intracellular signaling pathway due to its primary anti-proliferative effects; the non-Smad pathways, are less well-characterized, even though they also play non-trivial roles in carcinogenesis. Of the various non-Smad pathways of interest, a growing body of evidence has demonstrated the importance of Erk/MAPK signaling during cancer progression because TGF-ß-induced Erk activation is critical for EMT, a process that ultimately leads to tumor cell invasion and metastasis. To obtain a more complete quantitative understanding of the role of TGF-ß signaling during cancer progression, we have developed a comprehensive mathematical model of TGF-ß signaling that combines the Erk-MAPK pathways with the canonical Smad pathway using information from experimental observations reported in the literature. By describing how an extracellular TGF-ß ligand signal is sensed by receptors and transmitted via these two separate intracellular pathways, the model yields quantitative insight into how TGF-ß-induced responses can be modulated and regulated. The model also predicts possible dynamic behavior of the Erk-mediated pathway in cancerous cells that provide clues regarding possible explanatory mechanisms for the seemingly contradictory roles of TGF-ß during cancer progression. In particular, a comparison of the differences in the dynamics of transcriptionally active Smad and Erk between normal and cancerous signaling systems suggests that an imbalance between lipid-raft and non-raft TGF-ß receptor internalization can lead to TGF-ß-induced EMT in cancer cells.

Presenter(s): 
Once the content has been viewed and you have attested to it, you will be able to download and print a certificate for PDH credits. If you have already viewed this content, please click here to login.

Checkout

Checkout

Do you already own this?

Pricing


Individuals

AIChE Member Credits 0.5
AIChE Members $15.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
Non-Members $25.00
Language: